Literature DB >> 458630

Pharmacokinetics of heparin. I. Studies of dose dependence in rats.

T D Bjornsson, G Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 458630

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Oral heparin results in the appearance of heparin fragments in the plasma of rats.

Authors:  A K Larsen; D P Lund; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Intersubject variability in the anticoagulant response to heparin in vitro.

Authors:  T D Bjornsson; K M Wolfram
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Enhancement of colonic drug absorption by the paracellular permeation route.

Authors:  M Tomita; M Shiga; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

5.  Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route.

Authors:  Yiwei Qi; Ganlin Zhao; Dongfang Liu; Zachary Shriver; Mallik Sundaram; Shiladitya Sengupta; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-29       Impact factor: 11.205

Review 6.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.